Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × daromun × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 1

Interventions

Specimen Handling 3 Nivolumab 3 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Biopsy 2 talimogene laherparepvec 1 prednylidene 1 deltacortene 1 daromun 1 cemiplimab 1 Vitamin D 1 Sunscreening Agents 1 Standard of Care 1 Sirolimus 1 Prednisone 1 Photochemotherapy 1 Niacinamide 1 Mohs Surgery 1 MAPRE1 protein, human 1 Curettage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07227870 2026-03-09

L19IL2/TNF in Patients With Basal Cell Carcinoma

Philogen S.p.A.

Phase 2 Not yet recruiting

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡